Medidata Solutions ROE 2009-2018 | MDSO

Current and historical return on equity (ROE) values for Medidata Solutions (MDSO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Medidata Solutions ROE for the three months ending September 30, 2018 was 10.70%.
Medidata Solutions ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.05B $0.59B 9.50%
2018-06-30 $0.05B $0.56B 10.47%
2018-03-31 $0.05B $0.52B 9.25%
2017-12-31 $0.05B $0.51B 9.81%
2017-09-30 $0.04B $0.47B 9.74%
2017-06-30 $0.04B $0.44B 8.81%
2017-03-31 $0.03B $0.41B 9.02%
2016-12-31 $0.03B $0.40B 8.35%
2016-09-30 $0.03B $0.38B 7.86%
2016-06-30 $0.02B $0.32B 7.70%
2016-03-31 $0.02B $0.29B 6.51%
2015-12-31 $0.01B $0.28B 4.89%
2015-09-30 $0.01B $0.30B 4.26%
2015-06-30 $0.01B $0.29B 2.61%
2015-03-31 $0.01B $0.27B 2.75%
2014-12-31 $0.01B $0.27B 2.06%
2014-09-30 $0.00B $0.25B 0.43%
2014-06-30 $0.01B $0.23B 2.67%
2014-03-31 $0.01B $0.23B 4.35%
2013-12-31 $0.02B $0.23B 8.99%
2013-09-30 $0.02B $0.22B 13.69%
2013-06-30 $0.02B $0.16B 15.02%
2013-03-31 $0.02B $0.15B 15.44%
2012-12-31 $0.02B $0.14B 15.08%
2012-09-30 $0.03B $0.13B 26.61%
2012-06-30 $0.03B $0.12B 32.69%
2012-03-31 $0.04B $0.11B 43.84%
2011-12-31 $0.04B $0.10B 50.65%
2011-09-30 $0.03B $0.08B 51.76%
2011-06-30 $0.03B $0.07B 58.49%
2011-03-31 $0.02B $0.06B 55.49%
2010-12-31 $0.02B $0.05B 65.71%
2010-09-30 $0.01B $0.04B 44.04%
2010-06-30 $0.01B $0.03B 40.00%
2010-03-31 $0.01B $0.02B 32.00%
2009-12-31 $0.01B $0.02B 47.06%
2009-09-30 $0.00B $0.02B 51.61%
2009-06-30 $-0.00B $0.01B -28.57%
2009-03-31 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.433B $0.546B
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $19.074B 26.68
Athenahealth (ATHN) United States $5.336B 36.40
HMS Holdings Corp (HMSY) United States $3.121B 48.30
Omnicell (OMCL) United States $2.886B 63.88
IRHYTHM TECH (IRTC) United States $1.796B 0.00
Allscripts Healthcare Solutions (MDRX) United States $1.793B 20.12
Tabula Rasa Healthcare (TRHC) United States $1.362B 190.20
Quality Systems (NXGN) United States $1.025B 30.48
Invitae (NVTA) United States $0.988B 0.00
Inspire Medical Systems (INSP) $0.970B 0.00
111 Sponsored ADR (YI) China $0.817B 0.00
AXONICS MODULTN (AXNX) United States $0.401B 0.00
Computer Programs And Systems (CPSI) United States $0.359B 14.47
NantHealth (NH) United States $0.150B 0.00
Strata Skin Sciences (SSKN) United States $0.078B 0.00
FULGENT GENETIC (FLGT) United States $0.060B 0.00
Motus GI Holdings (MOTS) United States $0.053B 0.00
Digirad (DRAD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
Transgenomic (PRPO) United States $0.007B 0.00